Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interactions between immune-stimulating complexes (ISCOMs) and peritoneal mononuclear leucocytes.

D L Watson1, N A Watson, C Fossum

  • 1CSIRO Division of Animal Health, Armidale NSW, Australia.

Microbiology and Immunology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the humoral immune response to a multicomponent recombinant vaccine against S. aureus in healthy pregnant heifers.

Veterinary journal (London, England : 1997)·2018
Same author

Topical ofloxacin use in glucose-6-phosphate dehydrogenase deficiency-safe or unsafe?

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2017
Same author

Properties and mechanisms of drug release from matrix tablets containing poly(ethylene oxide) and poly(acrylic acid) as release retardants.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2016
Same author

Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.

Veterinary immunology and immunopathology·2014
Same author

The ISCOM: an immunostimulating complex.

Immunology today·2014
Same author

Pilot study assessing the efficacy of a novel treatment for sleep-related breathing disorders in patients undergoing sleep nasendoscopy: Our Experience.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2014

Immune-stimulating complexes (ISCOMs) containing influenza virus antigens show enhanced cell membrane interaction and uptake compared to micelles. PR8 ISCOMs significantly boosted immune cell Ia expression in mice.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Influenza virus envelope glycoproteins are key targets for immune responses.
  • Delivery systems like immune-stimulating complexes (ISCOMs) and micelles are used to present viral antigens.
  • Understanding the interaction of these delivery systems with cell membranes is crucial for vaccine development.

Purpose of the Study:

  • To compare the cellular interaction and immune-stimulating properties of influenza virus-derived ISCOMs and micelles.
  • To investigate the effect of PR8 ISCOMs on the expression of membrane Ia molecules on immune cells.

Main Methods:

  • Preparation of immune-stimulating complexes (ISCOMs) and micelles from human influenza virus (PR8) envelope glycoproteins and matrix proteins.
  • Electron microscopy to visualize the interaction of ISCOMs and micelles with cell membranes.

Related Experiment Videos

  • Intraperitoneal immunization of mice and subsequent analysis of peritoneal mononuclear leukocytes for Ia expression.
  • Main Results:

    • Electron microscopy revealed that ISCOMs exhibit a strong affinity for cell membranes and promote rapid internalization.
    • Micelles did not show the same level of membrane interaction or internalization as ISCOMs.
    • PR8 ISCOMs, but not matrix or micelles alone, significantly increased the expression of membrane Ia on peritoneal mononuclear leukocytes 24 hours post-immunization.

    Conclusions:

    • Immune-stimulating complexes (ISCOMs) demonstrate superior cell membrane affinity and internalization compared to micelles.
    • PR8 ISCOMs effectively enhance the expression of major histocompatibility complex class II (Ia) molecules on immune cells, suggesting potent immunomodulatory activity.
    • ISCOMs represent a promising platform for enhancing immune responses against influenza virus.